Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

Fig. 2

Western blot analyses of cell lysates labeled with the PD-L1 (SP263) antibody. Western blot analysis of cell lysates from adenocarcinoma cell lines loaded onto an SDS-PAGE gel and labeled with the PD-L1 (SP263) antibody. The antibody labeled a single band of the appropriate molecular weight for fully glycosylated PD-L1 (~55 kDa). Relative levels of PD-L1 immunoreactivity matched the known relative PD-L1 mRNA expression levels for these cell lines (H820 > MDA-MB231 > H1975 > Calu-3). PD-L1 programmed cell death ligand-1

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us